Lung cancer screening : panacea or pipe dream?GANTI, A. K; MULSHINE, J. L.Annals of oncology. 2005, Vol 16, pp ii215-ii219, issn 0923-7534, SUP2Conference Paper

Lung cancer○2: Screening and early diagnosis of lung cancerMULSHINE, J. L; SMITH, R. A.Thorax. 2002, Vol 57, Num 12, pp 1071-1078, issn 0040-6376, 8 p.Article

Considerations in population-based screening for the early detection of lung cancerMULSHINE, J. L; TOCKMAN, M. S.Lung biology in health and disease. 1992, Vol 58, pp 263-274, issn 0362-3181Article

Considerations in the development of lung cancer screening toolsMULSHINE, J. L; TOCKMAN, M. S; SMART, C. R et al.Journal of the National Cancer Institute. 1989, Vol 81, Num 12, pp 900-906, issn 0027-8874Article

Reducing lung cancer riskMULSHINE, J. L.Chest. 1999, Vol 116, Num 6, pp S493-S496, issn 0012-3692, SUPConference Paper

Phase I study of the pharmacokinetics of a radioimmunoconjugate, ⁹⁰Y-T101, in patients with CD5-expressing leukemia and lymphomaFOSS, F. M; RAUBITSCHECK, A; FRINCKE, J. M et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2691-2700, issn 1078-0432Article

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristineJOHNSON, B. E; BRIDGES, J. D; PASS, H et al.Journal of clinical oncology. 1996, Vol 14, Num 3, pp 806-813, issn 0732-183XArticle

Molecular markers in early cancer detection : new screening toolsMULSHINE, J. L; SCOTT, F.Chest. 1995, Vol 107, Num 6, pp 280S-286S, issn 0012-3692, SUPConference Paper

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancerEBINA, M; STEINBERG, S. M; MULSHINE, J. L et al.Cancer research (Baltimore). 1994, Vol 54, Num 9, pp 2496-2503, issn 0008-5472Article

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodiumGROSS, A. J; STEINBERG, S. M; JOHNSON, B. E et al.Cancer research (Baltimore). 1993, Vol 53, Num 1, pp 67-74, issn 0008-5472Article

p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical featuresMITSUDOMI, T; STEINBERG, S. M; GAZDAR, A. F et al.Oncogene (Basingstoke). 1992, Vol 7, Num 1, pp 171-180, issn 0950-9232Article

Direct intralymphatic injection of radiolabelled ¹¹¹In-T101 in patients with cutaneous T-cell lymphomaMULSHINE, J. L; CARRASQUILLO, J. A; PERENTESIS, P et al.Cancer research (Baltimore). 1991, Vol 51, Num 2, pp 688-695, issn 0008-5472, 8 p.Article

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intentMITSUDOMI, T; STEINBERG, S. M; OIE, H. K et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4999-5002, issn 0008-5472Conference Paper

Molecular Biomarkers Workshop : a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk PopulationsFIELD, J. K; BRAMBILLA, C; WEISS, S et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 339-345, issn 0169-5002Article

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitorsHONG, S. H; AVIS, I; VOS, M. D et al.Cancer research (Baltimore). 1999, Vol 59, Num 9, pp 2223-2228, issn 0008-5472Article

The early detection of second primary lung cancers by sputum immunostainingTOCKMAN, M. S; EROZAN, Y. S; PRABODH GUPTA et al.Chest. 1994, Vol 106, Num 6, pp 385S-390S, issn 0012-3692, SUPArticle

Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatinJOHNSON, B. E; SALEM, C; MULSHINE, J. L et al.Lung cancer. 1993, Vol 9, pp S21-S26, issn 0169-5002, SUPConference Paper

The correct dose : pharmacologically guided end point for anti-growth factor therapyMULSHINE, J. L; SHUKE, N; DAGHIGHIAN, F et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2743s-2746s, issn 0008-5472Conference Paper

Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancerAVIS, I. L; KOVACS, T. O. G; KASPRZYK, P. G et al.Journal of the National Cancer Institute. 1991, Vol 83, Num 20, pp 1470-1476, issn 0027-8874Article

Immunolymphoscintigraphy and the dose dependence of ¹¹¹In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphomaKEENAN, A. M; WEINSTEIN, J. N; MULSHINE, J. L et al.Cancer research (Baltimore). 1987, Vol 47, Num 22, pp 6093-6099, issn 0008-5472Article

Case report: clinical significance of the association of the Von Hippel-Lindau disease with pheochromocytoma and pancreatic apudomaMULSHINE, J. L; TUBBS, R; SHEELER, L. R et al.The American journal of the medical sciences. 1984, Vol 288, Num 5, pp 212-216, issn 0002-9629Article

Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissuesCOMBS, S. G; MARDER, R. J; MINNA, J. D et al.The Journal of histochemistry and cytochemistry. 1984, Vol 32, Num 9, pp 982-988, issn 0022-1554Article

Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses : A pilot studyDAHL, A. R; GROSSI, I. M; HOUCHENS, D. P et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3015-3024, issn 1078-0432Article

Autocrine growth loops dependent on peptidyl α-amidating enzyme as targets for novel tumor cell growth inhibitorsIWAI, N; MARTINEZ, A; MILLER, M.-J et al.Lung cancer. 1999, Vol 23, Num 3, pp 209-222, issn 0169-5002Article

Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancerCHAUDHRY, A; CARRASQUILLO, J. A; AVIS, I. L et al.Clinical cancer research. 1999, Vol 5, Num 11, pp 3385-3393, issn 1078-0432Article